FindTrial
Sign In

Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer

Deciphering tertiary lymphoid structure heterogeneity reveals prognostic signature and therapeutic potentials for colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078929
Enrollment
Unknown
Registered
2023-12-21
Start date
2023-12-22
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Observation group:None

Sponsors

The Sixth Affiliated Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) diagnosed with histologically confirmed colorectal cancer; (2) No history of neoadjuvant treatment; (3) Gene expression data and pathological imaging data are available

Exclusion criteria

Exclusion criteria: Unavailable follow-up information.

Design outcomes

Primary

MeasureTime frame
disease-free survival;—

Countries

China

Contacts

Public ContactFeng Gao

The Sixth Affiliated Hospital, Sun Yat-sen University

gaof57@mail.sysu.edu.cn+86 20 3825 4000

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026